Explore

Trendline Trendline
Definium Therapeutics Issues Inducement Grants to New Employees, Enhancing Workforce in Psychiatric Therapeutics

Definium Therapeutics Issues Inducement Grants to New Employees, Enhancing Workforce in Psychiatric Therapeutics

Definium Therapeutics Issues Inducement Grants to New Employees, Enhancing Workforce in Psychiatric Therapeutics
Trendline Trendline
10x Genomics Launches Atera Platform to Revolutionize Spatial Biology Analysis

10x Genomics Launches Atera Platform to Revolutionize Spatial Biology Analysis

10x Genomics Launches Atera Platform to Revolutionize Spatial Biology Analysis
Trendline Trendline
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call

Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call

Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call
Trendline Trendline
Biogen Stock Rises Following Analyst Upgrade and Drug Rights Acquisition

Biogen Stock Rises Following Analyst Upgrade and Drug Rights Acquisition

Biogen Stock Rises Following Analyst Upgrade and Drug Rights Acquisition
Trendline Trendline
AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call

AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call

AbCellera to Present Phase 1 Data for ABCL635 in Upcoming Earnings Call
Trendline Trendline
Rosen Law Firm Initiates Class Action Lawsuit Against Upstart Holdings for Securities Fraud

Rosen Law Firm Initiates Class Action Lawsuit Against Upstart Holdings for Securities Fraud

Rosen Law Firm Initiates Class Action Lawsuit Against Upstart Holdings for Securities Fraud
Trendline Trendline
Soley Therapeutics Unveils Preclinical Data on Anti-Tumor Activity of STX-6398 at AACR 2026

Soley Therapeutics Unveils Preclinical Data on Anti-Tumor Activity of STX-6398 at AACR 2026

Soley Therapeutics Unveils Preclinical Data on Anti-Tumor Activity of STX-6398 at AACR 2026
Trendline Trendline
Eli Lilly to Acquire Kelonia Therapeutics for $7 Billion, Expanding Cancer Cell Therapy Pipeline

Eli Lilly to Acquire Kelonia Therapeutics for $7 Billion, Expanding Cancer Cell Therapy Pipeline

Eli Lilly to Acquire Kelonia Therapeutics for $7 Billion, Expanding Cancer Cell Therapy Pipeline
Trendline Trendline
CPC Biotech Introduces AseptiQuik G Connector for Enhanced Bioprocessing

CPC Biotech Introduces AseptiQuik G Connector for Enhanced Bioprocessing

CPC Biotech Introduces AseptiQuik G Connector for Enhanced Bioprocessing
Trendline Trendline
Twist Bioscience to Announce Fiscal 2026 Q2 Financial Results with Investor Day Scheduled

Twist Bioscience to Announce Fiscal 2026 Q2 Financial Results with Investor Day Scheduled

Twist Bioscience to Announce Fiscal 2026 Q2 Financial Results with Investor Day Scheduled
Trendline Trendline
Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors

Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors

Rosen Law Firm Investigates Enphase Energy for Alleged Misleading Statements Affecting Investors
Trendline Trendline
ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning

ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning

ImmunityBio Faces Securities Fraud Lawsuit Amid FDA Warning